home / stock / irtc / irtc news


IRTC News and Press, iRhythm Technologies Inc. From 04/18/24

Stock Information

Company Name: iRhythm Technologies Inc.
Stock Symbol: IRTC
Market: NASDAQ
Website: irhythmtech.com

Menu

IRTC IRTC Quote IRTC Short IRTC News IRTC Articles IRTC Message Board
Get IRTC Alerts

News, Short Squeeze, Breakout and More Instantly...

IRTC - iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024

SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2024 ...

IRTC - Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down

2024-04-14 17:56:08 ET More on Boston Scientific, CONMED, etc. ResMed: Not A Sleeper Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash Boston Scientific: The Market's Newest Mega-Cap Needs A Breather Mizuho sees ResMed as 'overwhelming ben...

IRTC - When the Price of (IRTC) Talks, People Listen

2024-04-12 14:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

IRTC - 24 HOUR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - April 8, 2024) - Faruqi & Faruqi, LLP, a leading national s...

IRTC - DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 25, 2024) - Faruqi & Faruqi, LLP, a leading national ...

IRTC - DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 24, 2024) - Faruqi & Faruqi, LLP, a leading national ...

IRTC - DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of iRhythm Technologies

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In iRhythm To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - March 11, 2024) - Faruqi & Faruqi, LLP, a leading national ...

IRTC - iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers' $86.25 Million Option to Purchase Additional Notes

SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and help prevent disease, announced today the closing of its offering of 1.50% Co...

IRTC - iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029

SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict and help prevent disease, announced today the pricing of its offering of $575.0 m...

IRTC - iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes

SAN FRANCISCO, March 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (“iRhythm”) (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and help prevent disease, announced today that it intends to offer, subject to ma...

Previous 10 Next 10